HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 60 filers reported holding HARVARD BIOSCIENCE INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,989,000 | -0.3% | 1,330,391 | -0.3% | 6.38% | +12.0% |
| Q3 2017 | $5,005,000 | +49.0% | 1,334,591 | +1.3% | 5.69% | +59.6% |
| Q2 2017 | $3,358,000 | +7.7% | 1,316,993 | +9.8% | 3.57% | +27.5% |
| Q1 2017 | $3,119,000 | -11.6% | 1,199,575 | +3.7% | 2.80% | +38.1% |
| Q4 2016 | $3,527,000 | +98.6% | 1,156,332 | +77.0% | 2.03% | -32.3% |
| Q3 2016 | $1,776,000 | +39.0% | 653,124 | +46.2% | 2.99% | +120.9% |
| Q2 2016 | $1,278,000 | -5.3% | 446,707 | 0.0% | 1.35% | +16.8% |
| Q1 2016 | $1,349,000 | -14.0% | 446,707 | -1.2% | 1.16% | +16.1% |
| Q4 2015 | $1,569,000 | -2.3% | 452,258 | +6.5% | 1.00% | +12.1% |
| Q3 2015 | $1,606,000 | -30.9% | 424,744 | +4.1% | 0.89% | -24.1% |
| Q2 2015 | $2,325,000 | +76.1% | 407,861 | +79.8% | 1.17% | +82.1% |
| Q1 2015 | $1,320,000 | +56.4% | 226,826 | +52.3% | 0.64% | +50.5% |
| Q4 2014 | $844,000 | -8.8% | 148,924 | -26.8% | 0.43% | -25.7% |
| Q2 2014 | $925,000 | – | 203,314 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
| Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
| Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
| Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
| BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
| DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
| Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
| HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
| Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |